Actavis-Forest Labs is play on changes in health care By: MarketWatch February 18, 2014 at 09:06 AM EST Actavis is buying rival drug maker Forest Labs, in which Carl Icahn is a large shareholder. Read More >> Related Stocks: Actavis Plc Macy's